Skip to content

Hot Water Drinking Therapy in Achalasia

Efficacy and Safety Study of Hot Water Drinking Therapy in Achalasia Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01863966
Acronym
AHW
Enrollment
100
Registered
2013-05-29
Start date
2010-03-31
Completion date
2015-12-31
Last updated
2013-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia

Keywords

Achalasia, Hot water drinking therapy, Pneumatic dilation

Brief summary

From clinical observation that some achalasia patients drink water to help swallow food, the investigators have proposed a systemic hot water drinking therapy. This study is to observe its efficacy on achalasia symptoms and explore its mechanism.

Detailed description

1. Achalasia patients will participate hot water drinking therapy: to drink 200ml of hot water before and after a meal, as well as 2 hours before sleep and to chew food carefully and swallow with hot soup. 2. Patients are followed by achalasia associated symptom scores, barium esophagram and endoscopy. 3. If patients are unsatisfied with hot water drinking therapy, they receive pneumatic dilation

Interventions

OTHERhot water drinking therapy

Drink 200ml hot water 3min before and after a meal. Swallow food with hot water and drink 200ml hot water before sleep

Patients who are unsatisfied with hot water drinking therapy are to receive standard pneumatic dilation under endoscope

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* achalasia patients diagnosed by endoscopy, barium esophagram and manometry

Exclusion criteria

* could not drink water * poor compliance * severe comorbidities * esophageal stenosis secondary to erosions and cancer

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline achalasia symptom score at 1 monthbaseline and 1 monthDysphagia, Regurgitation and Chest Pain scores

Secondary

MeasureTime frameDescription
Change from baseline in barium esophagram at 1 yearbaseline and 1 yearmeasure esophageal diameter
Endoscopy at 1 yearyear 1esophageal bezoars and esophageal cancer
Pneumatic dilation rate and relative efficacyany timePatients who are unsatisfied with hot water drinking therapy are to receive pneumatic dilation
Number of patients with adverse effectsWeek 1adverse effects of drinking water like distention, nausea and belching
Change from baseline achalasia symptom scores at 5 yearsbaseline and 5 yearsDysphagia,Regurgitation and Chest Pain scores
Change from baseline in barium esophagram at 5 yearsbaseline and 5 yearsmeasure esophageal diameter
Endoscopy at 5 yearsyear 5esophageal bezoars and esophageal cancer
Change from baseline in achalasia symptom score at 1 yearbaseline and 1 yearDysphagia,Regurgitation and Chest Pain scores

Countries

China

Contacts

Primary ContactYutang Ren, M.D.
renytpumc@hotmail.com+86-020-62786224

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026